7,580.07

-140.32

-1.82%

51,770.31

-572.29

-1.09%

25,437.00

-747.70

-2.86%

2,811.84

-47.38

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,821.09

+336.23

+0.43%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqCM - Nasdaq Real Time Price USD

Pluri Inc. (PLUR)

1.2400 +0.0400 (+3.33%)

At close: October 30 at 4:00:01 PM EDT

1.2200 -0.0200 (-1.61%)

After hours: October 30 at 4:25:36 PM EDT

Loading Chart for PLUR

Chart Range Bar

Interval:

In partnership with ChartIQ

Pluri to Host Investor Conference Calls to Discuss Updates and Strategic Developments

Pluri to Host Investor Conference Calls to Discuss Updates and Strategic Developments

Pluri Chairman and Active Investor Alejandro Weinstein to Acquire EIB Loan, in Strong Vote of Confidence in the Company

Pluri Chairman and Active Investor Alejandro Weinstein to Acquire EIB Loan, in Strong Vote of Confidence in the Company

Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor

Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor

Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30%

Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30%

Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing

Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing

Pluri Inc. (PLUR): One of the Premier Lab-Grown Meat Stocks to Invest In

Pluri Inc. (PLUR): One of the Premier Lab-Grown Meat Stocks to Invest In

Pluri Insider Ups Holding During Year

Pluri Insider Ups Holding During Year

Pluri: Fiscal Q2 Earnings Snapshot

Pluri: Fiscal Q2 Earnings Snapshot

Pluri showcases cell expansion platform as Resbiomed program advances

Pluri showcases cell expansion platform as Resbiomed program advances

Pluri: Fiscal Q1 Earnings Snapshot

Pluri: Fiscal Q1 Earnings Snapshot

Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment

Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment

Mobilize your Website

View Site in Mobile | Classic

Share by: